Health ❯Healthcare ❯Medical Research ❯Oncology

Lung Cancer

IFITM3 Identified as Key Modulator of Immunotherapy Response in Small Cell Lung Cancer

The WCLC presentation outlines a pathway that elevates tumor MHC‑I via NLRC5 to bolster CD8+ T cell attack.

Early ctDNA Test Flags Which LS-SCLC Patients Benefit From Consolidation Immunotherapy

3-Week Radiotherapy Regimen Matches Survival, Cuts Severe Toxicity in Limited-Stage SCLC Trial

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

Iza-Bren Plus Osimertinib Delivers 100% Response in Small First-Line EGFR-Mutant NSCLC Cohort

Perioperative Nivolumab Preserves Quality of Life in Resectable NSCLC, WCLC 2025 Data Show

Comprehensive NGS Study Unveils Diverse Mutational Landscape in Lung Squamous Cell Carcinoma

AI Model Sybil Validated for Lung Cancer Risk Prediction in Diverse Populations